Bruce Boyd, DPM
Primary Podiatric Medicine · Savannah, TNNPI 1386715514
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $795 of the $1,206 with a category attached, or 65.9%. 6 manufacturers reported payments, led by Treace Medical Concepts, Inc. at 49.7% of the total.
Across 11 payments — averaging $109.64 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Treace Medical Concepts, Inc.$600
- Medtronic$242
- Fusion Orthopedics USA, LLC$208
- Kowa Pharmaceuticals America, Inc.$67
- Acumed LLC$66
- Averitas Pharma Inc.$23
What the payments were for
- Travel & lodging$41134%
- Food & beverage$79566%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Treace Medical Concepts, Inc. | 3 | $600 |
| Medtronic | 2 | $242 |
| Fusion Orthopedics USA, LLC | 1 | $208 |
| Kowa Pharmaceuticals America, Inc. | 3 | $67 |
| Acumed LLC | 1 | $66 |
| Averitas Pharma Inc. | 1 | $23 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Lapiplasty$411
- HawkOne$242
How this compares
Too few primary podiatric medicine providers in Tennesseeto place this figure against a meaningful peer group, so we don't.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Gentamicin Sulfate | 281 | $6,601 |
| Terbinafine Hcl | 316 | $5,638 |
| Fluocinonide | 81 | $3,142 |
| Gabapentin | 246 | $2,852 |
| Doxycycline Hyclate | 195 | $1,629 |
| Pregabalin | 124 | $1,616 |
| Cephalexin | 431 | $1,517 |
| Prednisone | 362 | $1,470 |
| Ammonium Lactate | 51 | $1,230 |
| Diclofenac Sodium | 88 | $1,198 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 124 | $779 |
| Clindamycin Hcl | 107 | $688 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 117 | $458 |
| Ciprofloxacin Hcl | 67 | $366 |
| Duloxetine Hcl | 17 | $307 |
Paid to pharmacies, not to this prescriber.
Other primary podiatric medicine in Savannah
- Lawrence BurnsNashville$4K
- Robert SpaldingSignal Mountain$685
- Vincent LongobardoCrossville$542
- Richard EbyChattanooga$298
- Bill VuongDayton$228
- Gary MantellMemphis$109
- Robert Mac ArthurColumbia$78
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.